Moreover, ACEI use may be related to other mechanisms involved in AD pathogenesis, including antagonizing Ang II’s ability to inhibit acetylcholine release and regulate inflammation, which are characteristics of other neurodegenerative diseases. Here, AGT is linked to Alzheimer disease.